France is represented in JPIAMR by The French National Research funding Agency (ANR) and the French National Institute of Health and Medical Research (Inserm).
The French National Research funding Agency (ANR) is a research funding organization. It was established by the French government in 2005 to fund research projects, based on competitive schemes giving researchers the best opportunities to realize their projects and paving the way for ground-breaking new knowledge. The role of the Agency is to bring more flexibility to the French research system, foster new dynamics and devise cutting edge-strategies for acquiring new knowledge. By identifying priority areas and fostering private-public collaborations, it also aims at enhancing the general level of competitiveness of both the French research system and the French economy. International activities are one of the priorities of the ANR; all scientific departments participate in ERA-Nets, JPIs and multilateral actions.
Founded in 1964, the French National Institute of Health and Medical Research (Inserm) is the only French public scientific and technological institute (Research Performing Organisation) to focus entirely on human health. In 2008 Inserm took on the responsibility for the strategic, scientific and operational coordination of biomedical research. This key role as coordinator comes naturally to Inserm thanks to the scientific quality of its teams and its ability to conduct translational research, from the laboratory to the patient’s bed.
In April 2009, national coordination was strengthened by the French National Alliance for Life Sciences and Health, which Inserm co-founded with other research institutes and the Association of University Presidents. To extend the strategic and programmatic coordination of research to all life and health sciences, the Alliance relies on 10 multi-organisation thematic institutes.
Lastly, Inserm plays a leading role in creating the European Research Area and boosts its standing abroad through close partnerships (teams and partner laboratories abroad). The institute is the first coordinator of Health Cooperation projects within the FP7.
National AMR research program and activities
AMR Research program
- France’s Antibiotic Resistance Priority Research Program (PPR) coordinated by Inserm (2019 – 2023): 40M€
- First PPR call for expression of interest
- Écoantibio 2: Plan national de réduction des risques d’antibiorésistance en médecine vétérinaire (2017 – 2021); the French national plan for the reduction of the risks of antimicrobial resistance in veterinary medicine
National AMR research calls
- ANR Generic call for proposals 2019 and 2020 + national priority on AMR
- Bilateral call between France (ANR) and Germany (BMBF) on AMR in 2019
- JPIAMR transnational call 2019 – “Diagnostics and Surveillance”: 1.5M€
- JPIAMR network call 2020 “Network Plus”
- JPI Water/JPI Oceans/JPIAMR joint AquaticPollutants call
Activities on AMR actions at national level
- Interministerial symposium Antibiotic resistance “Antimicrobial resistance monitoring: data for action”– Nov 20, 2019.
- International Course on Antibiotics and Resistance (ICARe) at Pasteur Institute, 2020.
- Launch of a new antibiotic resistance web portal with an interface bringing together academia, biotech, industry across the three ecosystems in November 2020.
- Six-month financial support from the French Minister of Higher Education, Research and Innovation to extend into 2021 the EU-JAMRAI network coordinated by INSERM, given the COVID-19 context.
- Restructuring of the surveillance networks under the aegis of Santé Publique France, considering a One Health approach in 2020.
- Meeting for the coordination of French research on antimicrobial resistance: Inserm, Feb 26, 2020.
National action plans
- Écoantibio 2: Plan national de réduction des risques d’antibiorésistance en médecine vétérinaire (2017-2021); the French national plan for the reduction of the risks of antimicrobial resistance in veterinary medicine
Management Board representative
- Philippe Bouvet, Agence Nationale de Recherche (ANR)
- Marie-Cecile Ploy, RESINFIT, University of Limoges and lnserm